Clinical Trials Logo

Clinical Trial Summary

This is a single center, double-blind, randomized trial in subjects with type 1 diabetes mellitus applying an adaptive design approach.


Clinical Trial Description

Subjects were be studied on two occasions, in randomized sequence, whereby glycemic excursions are assessed following an oral mixed meal challenge while treated with either insulin alone or co-administered insulin and glucagon. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04712266
Study type Interventional
Source Abvance Therapeutics
Contact
Status Completed
Phase Early Phase 1
Start date September 15, 2020
Completion date January 10, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT05967260 - DailyDose Smart Snack Study for T1D on MDI N/A
Completed NCT06097689 - A Pilot Study to Assess the Feasibility of a Novel Non-invasive Technology to Measure Changing Blood Glucose Levels in Adults With Type-1 Diabetes Mellitus N/A
Completed NCT03286816 - The Effect of Intravenous Lactate on Brain Lactate Concentrations During Hypoglycemia N/A
Recruiting NCT05221359 - Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes N/A
Recruiting NCT06382350 - Glycemic Excursions in Patients With Type 1 Diabetes Mellitus Using Closed-loop Systems
Recruiting NCT04266379 - Efficacy of Closed-loop Insulin Therapy in Adults Prone to Hypoglycemia N/A
Completed NCT03163511 - A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness Phase 1/Phase 2
Recruiting NCT05762107 - A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes Phase 2
Active, not recruiting NCT04614168 - Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes N/A
Completed NCT03028220 - Impact on Hypoglycaemia Awareness of Real Time CGM and Intermittent Continuous Glucose Data N/A
Enrolling by invitation NCT04233138 - SUPPORT Online Training Platform for Type 1 Diabetes Self-management Education and Support (SUPPORT) N/A
Recruiting NCT04664764 - Intermediate and Long Acting Insulin Young Children Type 1 Diabetes. Phase 4